Crinetics Pharmaceuticals, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending December 31, 2021: USD 249.60 M

Crinetics Pharmaceuticals, Inc. Common Stock Issued is USD 249.60 M for the Trailing 12 Months (TTM) ending December 31, 2021, a 495.65% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.
  • Crinetics Pharmaceuticals, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending December 31, 2020 was USD 41.90 M.
Key Data
Date Common Stock Issued Common Stock Repurchased Free Cash Flow Operating Cash Flow